-
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.
Genesis. 2001 Oct;31(2):85-94
PMID: 11668683
-
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Cancer Res. 2006 Aug 1;66(15):7473-81
PMID: 16885344
-
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89
PMID: 15977639
-
Identification of a cancer stem cell in human brain tumors.
Cancer Res. 2003 Sep 15;63(18):5821-8
PMID: 14522905
-
Origin of oligodendrocytes in the subventricular zone of the adult brain.
J Neurosci. 2006 Jul 26;26(30):7907-18
PMID: 16870736
-
High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.
Cancer Res. 2006 Aug 1;66(15):7429-37
PMID: 16885338
-
Neuron-specific enolase-cre mouse line with cre activity in specific neuronal populations.
Genesis. 2006 Mar;44(3):130-5
PMID: 16496331
-
Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.
Cancer Cell. 2005 Aug;8(2):119-30
PMID: 16098465
-
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Cancer Res. 2002 Oct 1;62(19):5551-8
PMID: 12359767
-
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.
Cell. 1999 Jun 11;97(6):703-16
PMID: 10380923
-
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
Nat Genet. 2000 May;25(1):55-7
PMID: 10802656
-
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
Cell. 1998 Oct 2;95(1):29-39
PMID: 9778245
-
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
J Biol Chem. 1998 May 29;273(22):13375-8
PMID: 9593664
-
Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.
Science. 1997 May 2;276(5313):791-4
PMID: 9115203
-
Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo.
Science. 2001 Dec 7;294(5549):2186-9
PMID: 11691952
-
Genetic pathways to glioblastoma: a population-based study.
Cancer Res. 2004 Oct 1;64(19):6892-9
PMID: 15466178
-
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation.
Cancer Cell. 2002 Mar;1(2):157-68
PMID: 12086874
-
TrkB has a cell-autonomous role in the establishment of hippocampal Schaffer collateral synapses.
J Neurosci. 2005 Apr 13;25(15):3774-86
PMID: 15829629
-
Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.
Cell. 2002 Apr 5;109(1):75-86
PMID: 11955448
-
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5
PMID: 10200246
-
Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Cancer Res. 2005 Mar 15;65(6):2065-9
PMID: 15781613
-
Differential expression of Rho family GTP-binding proteins and protein kinase C isozymes during C6 glial cell differentiation.
Brain Res Mol Brain Res. 1997 Apr;45(1):90-8
PMID: 9105674
-
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Neoplasia. 2005 Apr;7(4):356-68
PMID: 15967113
-
A unified hypothesis on the lineage of neural stem cells.
Nat Rev Neurosci. 2001 Apr;2(4):287-93
PMID: 11283751
-
Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner.
Cancer Res. 2006 Feb 15;66(4):1929-39
PMID: 16488991
-
Pten is essential for embryonic development and tumour suppression.
Nat Genet. 1998 Aug;19(4):348-55
PMID: 9697695
-
Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation.
Cancer Res. 2005 Jun 15;65(12):5172-80
PMID: 15958561
-
The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.
J Biol Chem. 1997 Jan 31;272(5):2927-35
PMID: 9006938
-
Neurofibromin, a tumor suppressor in the nervous system.
Exp Cell Res. 2001 Mar 10;264(1):19-28
PMID: 11237520
-
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Nat Genet. 2000 Sep;26(1):109-13
PMID: 10973261
-
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.
Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8
PMID: 9990064
-
The molecular and genetic basis of neurological tumours.
Nat Rev Cancer. 2002 Aug;2(8):616-26
PMID: 12154354
-
Cancerous stem cells can arise from pediatric brain tumors.
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83
PMID: 14645703
-
Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo.
Cancer Res. 2004 Nov 1;64(21):7773-9
PMID: 15520182
-
Pten regulates neuronal arborization and social interaction in mice.
Neuron. 2006 May 4;50(3):377-88
PMID: 16675393
-
Mammalian neural stem cells.
Science. 2000 Feb 25;287(5457):1433-8
PMID: 10688783
-
Malignant glioma: genetics and biology of a grave matter.
Genes Dev. 2001 Jun 1;15(11):1311-33
PMID: 11390353
-
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Cancer Res. 2001 May 1;61(9):3826-36
PMID: 11325859
-
Timing of p53 mutations during astrocytoma tumorigenesis.
Hum Mol Genet. 1993 Oct;2(10):1687-90
PMID: 8268922
-
Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas.
Lab Invest. 1998 Feb;78(2):165-74
PMID: 9484714
-
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
Cancer Cell. 2003 Feb;3(2):117-30
PMID: 12620407
-
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
Cancer Cell. 2006 Mar;9(3):157-73
PMID: 16530701
-
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Cancer Res. 2004 May 15;64(10):3525-32
PMID: 15150107
-
Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.
Glia. 2002 Sep;39(3):193-206
PMID: 12203386
-
Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.
J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32
PMID: 10564676
-
Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons.
Neuron. 1999 Jun;23(2):257-71
PMID: 10399933
-
Tumor spectrum analysis in p53-mutant mice.
Curr Biol. 1994 Jan 1;4(1):1-7
PMID: 7922305
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
N Engl J Med. 2005 Mar 10;352(10):987-96
PMID: 15758009
-
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
Curr Biol. 1998 Oct 22;8(21):1169-78
PMID: 9799734